Long‐term survival (incidence of mortality) · interstitial lung disease
Pulmonary rehabilitation showed no clear difference in long‐term survival (incidence of mortality) compared with no pulmonary rehabilitation (low certainty).
1 finding from 1 review
Meters change from baseline in 6MWD · idiopathic pulmonary fibrosis
1 finding from 1 review
Cardiovascular mortality · health problem or population
Summary of findings table ‐ Psychological treatment showed no clear difference in cardiovascular mortality ‐ long‐term compared with control; GRADE not reported.
1 finding from 1 review
Cognitive function · people with dementia
1 finding from 1 review
Functional status (change from baseline, long term) BADLS · people with dementia
1 finding from 1 review
Change in NPI · people with dementia
1 finding from 1 review
Service utilisation ‐ referral to mental health team ‐ long term (7 to 12 months post intervention)Â · adults with common mental disorders
Primary‐level worker‐led collaborative care may leads to lower service utilisation ‐ referral to mental health team ‐ long term (7… compared with usual care (low certainty).
1 finding from 1 review
Comfort · adults in the ICU, requiring respiratory support
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Comfort · adults in the ICU, requiring respiratory support
1 finding from 1 review
Intervention not reported
Discharge from hospital to new long‐term care placement 536 participants (1 study)
The intervention showed no clear difference in discharge from hospital to new long‐term care placement 536… (low certainty).
1 finding from 1 review
Infection rate Long term (30 to 365 days) · people with unruptured intracranial aneurysms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Infection rate Long term (30 to 365 days) · people with unruptured intracranial aneurysms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life: clinically important change in quality of life · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive functioning Clinically important change in cognitive functioning as defined by each study · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Functioning: specific ‐ social ‐ clinically important change · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life: clinically important change in quality of life · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive functioning Clinically important change in cognitive functioning as defined by each study · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Functioning: specific ‐ social ‐ clinically important change · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Long‐term neurological sequelae other than hearing loss defined as sequelae present between 6 weeks after hospital discharge and the last time point reported in the study · children with acute bacterial meningitis
The intervention may leads to higher long‐term neurological sequelae other than hearing loss defined as… (low certainty).
1 finding from 1 review
Adverse events ‐ nasopharyngitis, including sore throat · patients with severe chronic rhinosinusitis with nasal polyps
Anti‐IL‐4Rα mAb (dupilumab) showed no clear difference in adverse events ‐ nasopharyngitis, including sore throat (longest… compared with placebo (on top of topical steroids) (low certainty).
1 finding from 1 review